Skip to content

Nutrition Optimalization Among Pregnant Women to Improve Maternal and Neonatal Outcome in DKI Jakarta

Maternal Optimalization on Nutrition for Better Pregnancy Outcomes (MONAS Study)

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06268509
Acronym
MONAS
Enrollment
245
Registered
2024-02-20
Start date
2023-04-01
Completion date
2024-08-31
Last updated
2024-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asphyxia Neonatorum, Intrauterine Infection, IUGR, Low; Birthweight, Extremely (999 Grams or Less), Maternal Death, Neonatal Death, Preeclampsia, Pregnancy Complications, Pregnancy Hemorrhage, Preterm Birth

Brief summary

The goal of this MONAS Study is to learn about comprehensive monitoring and nutritional intervention among pregnant women in order to improve maternal and neonatal outcomes. The main questions it aims to answer are: 1. Are comprehensive monitoring and nutritional intervention among pregnant women can improve maternal outcomes (maternal death, preterm labour, preeclampsia, intrauterine infection, and bleeding during pregnancy and delivery) compared to standard maternal health services? 2. Are comprehensive monitoring and nutritional intervention among pregnant women can improve neonatal outcomes (neonatal death, low birth weight, intrauterine growth restriction, and neonatal asphyxia) compared to standard maternal health services? Participants in the intervention group will receive: * Fetomaternal ultrasound examination each trimester * Complete laboratory examination for nutritional panel (complete blood count with reticulocyte profile and iron profile, vitamin D level, zinc level, fatty acid profile, electrophoresis for Thalassemia) as an addition to standard maternal routine laboratory examination * Supplements: multivitamin, minerals, vitamin D, fatty acid * Intervention regarding any abnormal results of nutritional panel * All standard maternal health services according to Indonesian Ministry of Health protocol Participants in the control group will receive: \- All standard maternal health services according to Indonesian Ministry of Health protocol

Interventions

DIAGNOSTIC_TESTNutritional panel laboratory examination

As stated in group description

DIETARY_SUPPLEMENTPregnancy supplements (other than provided by Ministry of Health)

As stated in group description

DIAGNOSTIC_TESTFetomaternal ultrasound

As stated in group description

Sponsors

Dinas Kesehatan DKI Jakarta
CollaboratorUNKNOWN
Fakultas Kedokteran Universitas Indonesia
CollaboratorOTHER
Dr Cipto Mangunkusumo General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Pregnancy in 1st trimester * Gestational age less than 10 weeks * Living in Jakarta greater area * Agree to participate

Exclusion criteria

* Assisted reproductive technology (IVF) * History of polycystic ovary syndrome * History of chronic hypertension * History of diabetes mellitus * History of preeclampsia in the previous pregnancy * Had chronic disease: heart disease, autoimmune disease, malignancy, chronic lung disease * Planning to have delivery outside Jakarta greater area * Poor obstetric history (miscarriage/ abortion more than 3 times)

Design outcomes

Primary

MeasureTime frameDescription
Composite of poor maternal outcomesAt anytime between 20 weeks of gestational age until 28 days after deliveryNumber of participants with a combination of maternal death, preterm labour, preeclampsia, intrauterine infection, and bleeding during pregnancy and or after delivery
Composite of poor neonatal outcomesAfter delivery of participants (any gestational age) until 28 days of chronological ageA number of baby born from participants with a combination of neonatal death, low birth weight, intrauterine growth restriction, neonatal asphyxia, and need of admission to intensive care untill 28 daya of age

Countries

Indonesia

Contacts

Primary ContactHardya G Hikmahrachim, M.D., M.Sc
hardyagustada@yahoo.com+6281386696655
Backup ContactYurika E Susanti, M.D.
yurika.elizabeth.s@gmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026